home

Mission Statement

The mission of the Psychiatric Cell Map Initiative (PCMI) is to bridge the gap between the genome and clinic in the field of neuropsychiatric disorder research by systematically mapping the physical and genetic interaction networks underlying these disorders, including autism spectrum disorders, Tourette disorder, epilepsy, intellectual disability, and schizophrenia. This will form a key resource ...

Read More

The mission of the Psychiatric Cell Map Initiative (PCMI) is to bridge the gap between the genome and clinic in the field of neuropsychiatric disorder research by systematically mapping the physical and genetic interaction networks underlying these disorders, including autism spectrum disorders, Tourette disorder, epilepsy, intellectual disability, and schizophrenia. This will form a key resource for precision medicine.

Vision

We are addressing the substantial challenge of translating exciting gene discoveries in ASD to an actionable understanding of the underlying neurobiology

What is PCMI?

An interdisciplinary, collaborative effort spanning multiple institutions, leveraging recent successes in gene discovery to generate critical insights into the pathway-level biology of psychiatric disorders. This knowledge will aid in the development of more efficacious treatments.

March

26

LPPHC Intensive Services Grand Rounds

Read More

May

15

Understanding the Basis of Sex Bias in Autism

Read More

October

16

Funding Academic Neurotherapeutic Discovery with Charles Cywin

Read More